CTOs on the Move

Card Guard AG

www.cardguard.com

 
Card Guard AG is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

California Home Medical Eqpt

California Home Medical Eqpt is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BIOPAC Systems

ElectrodeSales.com is the online sales outlet of BIOPAC Systems, Inc., a leading manufacturer of electrodes for life science data acquisition and analysis. We offer disposable Ag-AgCl electrodes, reusable electrodes, snap electrodes, needle electrodes,

AirSep

We offer firefighting items, First Aid kits, EMT, 72 hr survival kits and supplies for individuals, Search and Rescue, CERT, Police, Military and Fire Rescue. We are dedicated to supplying everyone with the necessary supplies to be fully prepared for any

BaroSense

BaroSense is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LumiThera

At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company`s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological “drusen” following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area. The Valeda Light Delivery System is CE Marked. The device is not for sale in the USA.